New analysis of LIFE trial shows reduction of new-onset atrial fibrillation with losartan

July 2005    Volume 12, Issue 4   Br J Cardiol 2005;12:268-9

Authors:
Brian Crichton

A new analysis of the LIFE study has shown that losartan can reduce new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy. General practitioner Brian Crichton summarises this new analysis and explains how losartan might achieve these effects.

back to top

Comments

There are currently no comments for this article - leave a comment

You must be logged in to post a comment.
Not yet a member? Register now for free.

back to top